Navigation Links
Guidelines Issued to Resolve Temporary Facial Paralysis
Date:11/7/2012

WEDNESDAY, Nov. 7 (HealthDay News) -- New guidelines recommend steroid pills to treat initial symptoms of a condition called Bell's palsy that temporarily paralyzes facial muscles.

Steroid pills, sometimes in conjunction with medications that target viruses, are already a common treatment for the condition, said ear, nose and throat specialist Dr. Jay Rubinstein, professor of otolaryngology at University of Washington, Seattle, commenting on the guidelines.

Bell's palsy is challenging to treat because 85 percent of patients will recover on their own, but it will persist in the other 15 percent, he said.

"We give steroids to try to get a better result on those 15 percent and to speed up the whole process," he said. "We think that facial paralysis recovers faster with steroids than not, but we have precious little proof of that."

Patients with Bell's palsy suddenly develop paralysis on one side of their face, he said. The cause isn't clear, but researchers suspect it occurs when a herpes virus -- the same kind that leads to cold sores -- strikes the nerves in the face.

The steroids appear to work by reducing swelling in the facial nerves, he said.

The new guidelines, published online Nov. 7 in the journal Neurology, note that several studies support the use of steroids in the short term to treat the condition. However, certain patients -- obese people, those with uncontrolled diabetes and patients who can't tolerate steroids -- may have complications.

Adding antiviral medication to a steroid treatment may help a bit, the guidelines suggest.

Guidelines author Dr. Gary Gronseth, of the University of Kansas Medical Center in Kansas City, said patients might be offered steroid pills and antiviral medication "because of the possibility of modest recovery with combination treatment."

However, "they should be aware that the benefit of adding antivirals to steroid treatment is likely slight," he added in a journal news release.

More information

For details about Bell's palsy, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Jay Rubinstein, M.D., Ph.D., professor, otolaryngology, University of Washington, Seattle; Neurology, news release, Nov. 7, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
2. UMSOM dean urges caution in revising diagnostic guidelines for gestational diabetes
3. Guidelines developed for extremely premature infants at NCH proven to be life-changing
4. New pediatric heart failure guidelines a first in Canada
5. Modeling Good Research Practices guidelines for modeling in health care research available now
6. U-M guidelines help family physicians evaluate, manage urinary incontinence for women
7. New clinical guidelines for managing hypothyroid disease presented in Thyroid Journal
8. New Strep Throat Guidelines Tackle Antibiotic Resistance
9. Thyroid Treatment Guidelines for Pregnant Women Revised
10. Study Questions Guidelines on Radiation for Older Breast Cancer Patients
11. Few Follow Car Safety Guidelines for Kids, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Guidelines Issued to Resolve Temporary Facial Paralysis
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, Inc., ... of SentinelSecure™, version 3.0, will be available in a managed cloud services model, ... SentinelSecure™ comes with several new enhancements including support for caller ID and network ...
(Date:9/25/2017)... ... 2017 , ... Nissar A. Darmani, PhD, has been awarded a record WesternU ... nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences in ... is from the National Cancer Institute (NCI) arm of the National Institutes of Health ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough to remember what ... headgear so wired up and containing so much metal that jokes about radio reception ... its treatments can barely be observed. As a result, it’s now a billion-dollar industry ...
(Date:9/25/2017)... ... September 25, 2017 , ... Winners in ... announced on Friday, September 22 during a gala event in New York City. ... achievements and HR-related products and suppliers who help to create and drive great ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on your average daily ... “more than any sane human could possibly complete,” then you’re all too familiar with ... desperately trying to be everything to everybody all the time. , Self-proclaimed overly productive ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology: